Hyperdense Middle Cerebral Artery Sign As A Predictor of First-Pass Recanalization and Favorable Outcomes in Direct Thrombectomy Patients

Overview

Journal Clin Neuroradiol

Specialties Neurology
Radiology

Date 2024 Dec 20

PMID 39704829

Authors

Yiyang Sun

Dapeng Sun

BaiXue Jia

Xiaochuan Huo

Xu Tong

Anxin Wang

Ning Ma

Feng Gao

Dapeng Mo

Zhongrong Miao

Affiliations

Soon will be listed here.

Abstract

Background: The Hyperdense Middle Cerebral Artery Sign (HMCAS) is an early marker of acute MCA occlusion on non-contrast CT (NCCT), which has been linked with stroke type and thrombus composition.

Aims: To assess the prognostic value of HMCAS in M1 occlusion patients treated with endovascular thrombectomy and explore its predictive value across different patients.

Methods: Patients with M1 occlusion were selected from the ANGEL-ACT registry, which comprised 1793 individuals. Cohorts were divided based on the presence of HMCAS. The primary outcome was functional independence (mRS 0-2) at 90 days. Secondary outcomes included excellent outcome (mRS 0-1), good functional outcome (mRS 0-3), modified first pass effect (mFPE), successful recanalization, intracranial hemorrhage, and 90-day mortality. Propensity score matching (PSM) was employed to adjust for confounders, with 96 patients in each matched group. Subgroup analysis was performed to determine whether the effect of HMCAS on clinical outcomes differed between groups.

Results: Among 714 acute M1 occlusion patients, 96 (13.4%) had HMCAS. PSM analysis showed that HMCAS was independently associated with mFPE (OR: 1.97, 95% CI: 1.04-3.75, p = 0.038) but had no significant effects on other clinical outcomes. There was a significant association between HMCAS and functional independence for patients who underwent direct thrombectomy but not for patients who underwent bridging therapy (P for interaction = 0.033).

Conclusion: This study indicates that in patients with acute M1 occlusion undergoing EVT, HMCAS on pretreatment NCCT is not significantly associated with functional independence but is linked to a higher first-pass recanalization rate. Its clinical impact on outcomes depends on whether intravenous thrombolysis is administered before thrombectomy.

References

Goyal M, Menon B, van Zwam W, Dippel D, Mitchell P, Demchuk A . Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016; 387(10029):1723-31. DOI: 10.1016/S0140-6736(16)00163-X. View

Chen W, Wu J, Wei R, Wu S, Xia C, Wang D . Improving the diagnosis of acute ischemic stroke on non-contrast CT using deep learning: a multicenter study. Insights Imaging. 2022; 13(1):184. PMC: 9723089. DOI: 10.1186/s13244-022-01331-3. View

Mair G, Boyd E, Chappell F, von Kummer R, Lindley R, Sandercock P . Sensitivity and specificity of the hyperdense artery sign for arterial obstruction in acute ischemic stroke. Stroke. 2014; 46(1):102-7. PMC: 4338528. DOI: 10.1161/STROKEAHA.114.007036. View

Leys D, Pruvo J, Godefroy O, Rondepierre P, Leclerc X . Prevalence and significance of hyperdense middle cerebral artery in acute stroke. Stroke. 1992; 23(3):317-24. DOI: 10.1161/01.str.23.3.317. View

Tomsick T, Brott T, Chambers A, Fox A, Gaskill M, Lukin R . Hyperdense middle cerebral artery sign on CT: efficacy in detecting middle cerebral artery thrombosis. AJNR Am J Neuroradiol. 1990; 11(3):473-7. PMC: 8367461. View

Liebeskind D, Sanossian N, Yong W, Starkman S, Tsang M, Moya A . CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke. 2011; 42(5):1237-43. PMC: 3094751. DOI: 10.1161/STROKEAHA.110.605576. View

Tomsick T, Brott T, Olinger C, Barsan W, Spilker J, Eberle R . Hyperdense middle cerebral artery: incidence and quantitative significance. Neuroradiology. 1989; 31(4):312-5. DOI: 10.1007/BF00344173. View

Sangpetch S, Wantaneeyawong C, Soontornpun A, Tiyapun N, Tanprawate S, Thiankhaw K . Implications of the Presence of Hyperdense Middle Cerebral Artery Sign in Determining the Subtypes of Stroke Etiology. Stroke Res Treat. 2021; 2021:6593541. PMC: 8612777. DOI: 10.1155/2021/6593541. View

Manelfe C, Larrue V, von Kummer R, Bozzao L, Ringleb P, Bastianello S . Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke. 1999; 30(4):769-72. DOI: 10.1161/01.str.30.4.769. View

10.

Kim S, Baek B, Lee Y, Yoon W . Clinical implications of CT hyperdense artery sign in patients with acute middle cerebral artery occlusion in the era of modern mechanical thrombectomy. J Neurol. 2017; 264(12):2450-2456. DOI: 10.1007/s00415-017-8655-0. View

11.

Ume K, Dandapat S, Weber M, Zevallos C, Fifer A, Levy A . Absent hyperdense middle cerebral artery sign is associated with poor functional outcome after mechanical thrombectomy. Int J Stroke. 2021; 17(1):101-108. DOI: 10.1177/1747493021991972. View

12.

Mokin M, Morr S, Natarajan S, Lin N, Snyder K, Hopkins L . Thrombus density predicts successful recanalization with Solitaire stent retriever thrombectomy in acute ischemic stroke. J Neurointerv Surg. 2014; 7(2):104-7. DOI: 10.1136/neurintsurg-2013-011017. View

13.

Mowla A, Razavi S, Lail N, Mohammadi P, Shirani P, Kavak K . Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients. J Neurol Sci. 2021; 429:117618. DOI: 10.1016/j.jns.2021.117618. View

14.

Kang Z, Wu L, Sun D, Zhou G, Wu X, Qiu H . Proximal hyperdense middle cerebral artery sign is associated with increased risk of asymptomatic hemorrhagic transformation after endovascular thrombectomy: a multicenter retrospective study. J Neurol. 2022; 270(3):1587-1599. PMC: 9971136. DOI: 10.1007/s00415-022-11500-5. View

15.

Kolominsky-Rabas P, Weber M, Gefeller O, Neundoerfer B, Heuschmann P . Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001; 32(12):2735-40. DOI: 10.1161/hs1201.100209. View

16.

Krishnamurthi R, Barker-Collo S, Parag V, Parmar P, Witt E, Jones A . Stroke Incidence by Major Pathological Type and Ischemic Subtypes in the Auckland Regional Community Stroke Studies: Changes Between 2002 and 2011. Stroke. 2017; 49(1):3-10. DOI: 10.1161/STROKEAHA.117.019358. View

17.

Staessens S, Denorme F, Francois O, Desender L, Dewaele T, Vanacker P . Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance. Haematologica. 2019; 105(2):498-507. PMC: 7012484. DOI: 10.3324/haematol.2019.219881. View

18.

Brinjikji W, Duffy S, Burrows A, Hacke W, Liebeskind D, Majoie C . Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome: a systematic review. J Neurointerv Surg. 2016; 9(6):529-534. PMC: 6697418. DOI: 10.1136/neurintsurg-2016-012391. View

19.

Mohammaden M, Haussen D, da Camara C, Pisani L, Gadea M, Al-Bayati A . Hyperdense vessel sign as a potential guide for the choice of stent retriever versus contact aspiration as first-line thrombectomy strategy. J Neurointerv Surg. 2020; 13(7):599-604. DOI: 10.1136/neurintsurg-2020-016005. View

20.

Vandelanotte S, Staessens S, Francois O, De Wilde M, Desender L, De Sloovere A . Association between thrombus composition and first-pass recanalization after thrombectomy in acute ischemic stroke. J Thromb Haemost. 2024; 22(9):2555-2561. DOI: 10.1016/j.jtha.2024.05.034. View